InsidersTradesSigma
Unicycive Therapeutics, Inc.: directors' dealings · United States · SEC (Form 4)
SEC:unicycive-therapeutics-inc-f75cd7US·SEC (Form 4)Mcap 220M€Healthcare
Explore the full management transaction log of Unicycive Therapeutics, Inc., a publicly traded company based in United States. Shares trade on US US, under the authority of SEC (Form 4). Operating in the Healthcare sector, Unicycive Therapeutics, Inc. has published 1 insider filings. Market capitalisation: €220m. The latest transaction was reported on 17 May 2022 (Acquisition). Among the most active insiders: Schiller Brigitte. The full history is free.
1
Insider Decl.
0
Thresholds
€11,855
1 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
8.24 €
Analyst consensus
10 analystsStrong buy
15.00 €Target 40.99 €(+397%)90.00 €
Income statement
Net income−26.6 M€0.0% margin
Valuation
PER (forward)1.3x
P/Book5.5x
Balance sheet & cash
Market cap220.0 M€
Total debt199 k€
Free Cash Flow−31.3 M€
Debt / Equity2%
Profitability & ownership
ROE-163.1%
ROA-40.6%
% insiders2.4%
% institutions37.5%
Last declaration on 17 May 2022
Declarations1 total
Executives▲Purchase29SEC
€11,85515,000 shares@ €0.79030.0054% mcap100.0% of flow
Common Stock
SEC:0001213900-22-027501:0·
Ideal exit: 10 Feb 2023 (T+270)
1 of 1 declaration